Olympus Launches Five New Urology Devices, Expanding Complete Portfolio
Share:
New Olympus Advantage Program Offers Improved Capital-Offset Scenarios with Purchase of Disposable Devices
CENTER VALLEY, Pa. — Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today that it is unveiling several new Urology devices at the upcoming American Urological Association Annual Meeting in New Orleans. These developments include:
   -- GLIDEWIRE® Hydrophilic Coated Urologic Guidewire: Olympus is now the
       exclusive distributor of the most-requested brand in guidewire, the
       Terumo GLIDEWIRE® Urologic Guidewire.
   -- ShockPulse- SE: This next generation CyberWand, Dual Action Lithotripsy
       System with integrated suction and hand activation, fragments and
       removes stones even more efficiently.
   -- UltraTrack Hybrid Guidewire: This everyday guidewire combines the
       flexibility of a hydrophilic wire at the tip and a stiff body to
       maintain position and assist in device passage.
   -- UroPass Access Sheath full portfolio: For establishing atraumatic
       passage, the hydrophilic-coated sheath and gradual tapered dilator tip
       eases placement and allows for multiple passage of endoscopes and
       retrieval devices. The sheath provides fast access through the urethra
       and to the kidney, enabling multiple passages of instruments safely.
   -- 200 Series Laser Fiber: This thin fiber balances a small diameter with
       the optimal laser energy transmission, allowing scope flexibility and
       improved irrigation. This slim fiber complements the full offering of
       lasers and laser fibers.
In addition, Olympus is pleased to extend its Olympus Advantage Program to the Urology market. The Olympus Advantage Program is designed to reduce the overall cost of Olympus capital products such as rigid and flexible scopes, cameras and processors. Customers who choose the high quality Stone disposable devices, such as guidewires, balloons and stents, will receive credits toward their Olympus capital equipment costs while dramatically reducing the overall spend.
"This is an exciting time to be a medical device company in the Urology space," said Richard Reynolds, Executive Vice President - Sales, Marketing Shared Services of the Medical Systems Group at Olympus Corporation of the Americas. "New advancements in imaging, stone management and the use of proprietary tumor detection technology, combined with our commitment to valuable partnerships and innovations in pricing structures, are helping physicians meet the triple aim of healthcare reform by improving quality, reducing costs and enhancing patient satisfaction."
Designed with performance and patient safety in mind, the new Urology line-up can help facilities address the three key requirements of healthcare reform. Some examples include:
   -- Increased Quality of Care: Design advancements in the stone and wire
       products mean more precise access to complicate anatomy with less risk
       of trauma.
   -- Decreased Costs: Efficiency advancements of the devices mean costs saved
       in terms of OR time; new pricing structures allow more savings to be
       realized.
   -- Enhanced Patient Satisfaction: Protection against perforation and trauma
       during urological treatments can mean a reduced chance of complications
       and faster healing for patients.
The urology disposables line-up will be showcased at the American Urological Association's 2015 Annual Meeting to be held on May 15-19 in New Orleans, La. Healthcare providers are invited to visit the Olympus Booth #101 for a demonstration.
For more information about the new Olympus Urology disposables line-up, please contact Olympus customer service at 1-800-848-9024 or visit medical.olympusamerica.com/procedure/stone-management.
About Olympus Medical Systems Group
Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.
For more information visit Olympus at medical.olympusamerica.com.
Source
Olympus
Contact:
Michael Levey
Olympus Corporation of the Americas
484-896-5120
michael.levey@olympus.com
Web Site: http://medical.olympusamerica.com
